Home › Research › Biomarkers
Genetic architecture of Alzheimer’s disease-related plasma biomarkers
Aaltonen A, Palviainen T, Heikkinen S, Herukka S, Hiltunen M, Kokkola T, Kärkkäinen S, FinnGen et al.. medRxiv, 2025-12-18
Topic: Plasma and spinal-fluid biomarkers
Plain-language summary
INTRODUCTION Alzheimer’s disease-related plasma biomarker interrelationships and factors underlying these associations remain poorly understood. To address this, we studied the heritability of plasma biomarkers and their associations with cognition. METHODS This study included 696 twins, aged 65–85, without a diagnosis of Alzheimer’s disease. Plasma amyloid beta 42 and 40, phosphorylated tau (p-tau) 181 and 217, neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) were quantified with Simoa HD-X, and cognition was assessed with cCOG. Statistical analyses were done with multivariate twin models and linear mixed effect models. RESULTS Phenotypic associations between p-tau181, p-tau217, NfL and GFAP were 0.22–0.73. Heritability estimates were 0.39–0.66, and genetic correlations were 0.32–0.67. P-tau181 and p-tau217 were associated with cognition (β = −0.12; 95% CI: −0.19–-0.04 and β = −0.19; 95% CI: −0.26–-0.12, respectively). DISCUSSION The observed phenotypic and genetic associations highlight shared underlying mechanisms among plasma biomarkers.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Aaltonen, A., Palviainen, T., Heikkinen, S., Herukka, S., Hiltunen, M., Kokkola, T., et al. (2025). Genetic architecture of Alzheimer’s disease-related plasma biomarkers. medRxiv. https://doi.org/10.64898/2025.12.17.25342458
Vancouver
Aaltonen A, Palviainen T, Heikkinen S, Herukka S, Hiltunen M, Kokkola T, et al. Genetic architecture of Alzheimer’s disease-related plasma biomarkers. medRxiv. 2025. doi:10.64898/2025.12.17.25342458.
BibTeX
@article{aaltonen2025-5f0d801a,
author = {Aaltonen, A. and Palviainen, T. and Heikkinen, S. and Herukka, S. and Hiltunen, M. and Kokkola, T. and Kärkkäinen, S. and FinnGen and others},
title = {{Genetic architecture of Alzheimer’s disease-related plasma biomarkers}},
journal = {medRxiv},
year = {2025},
doi = {10.64898/2025.12.17.25342458},
url = {https://doi.org/10.64898/2025.12.17.25342458}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- RESULTS Phenotypic associations between p-tau181, p-tau217, NfL and GFAP were 0.22–0.73.
- P-tau181 and p-tau217 were associated with cognition (β = −0.12; 95% CI: −0.19–-0.04 and β = −0.19; 95% CI: −0.26–-0.12, respectively).
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants696
- Evidence strengthLow
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 27 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 17 of the 62 points we could judge it on, which is 27 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (medRxiv) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 696 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 17 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 17 of the 62 points we could judge it on is 27 out of 100. |
| Total | 27 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “p-tau217”
692 studies in the library carry the topic tag “p-tau217”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 692 tagged studies.